期刊文献+

微管不稳定蛋白和高迁移率蛋白A2在前列腺癌组织的表达及其临床意义 被引量:6

Expression and clinical significance of stathmin,high mobility group A2 in prostate carcinoma tissues
原文传递
导出
摘要 目的观察前列腺癌组织中微管不稳定蛋白(Stathmin)和高迁移率蛋A2(HMGA2)的表达,分析两者与前列腺癌临床病理意义的关系。方法收集2013年1月至2019年8月临沂市人民医院和青岛市立医院治疗并经病理学确诊的23例前腺列增生组织和75例前列腺癌组织标本,前列腺电切术取23例前列腺增生组织标本作为对照组,应用免疫组织化学方法检测其中的Stathmin和HMGA2的表达水平,并结合临床资料进行统计学分析,各组间比较采用χ2检验。结果前列腺癌组织中的Stathmin阳性表达率为80.00%(60/75),明显高于前腺列增生组织阳性表达率21.74%(5/23),差异有统计学意义(t=26.751,P<0.05);Stathmin表达水平与前列腺癌组织学分级、临床分期明显相关(t=7.204、5.357,P<0.05)。前列腺癌组织中HMGA2阳性表达率72.00%(54/75),明显高于前腺列增生组织阳性表达率13.04%(3/23),差异有统计学意义(t=25.143,P<0.05);HMGA2表达水平与前列腺癌组织学分级、精囊腺侵犯和临床分期明显相关(t=9.560、4.734、4.688,P<0.05)。结论Stathmin和HMGA2过度表达在前列腺癌的发生发展过程中发挥一定程度作用。 Objective To investigate the expression of stathmin and high mobility group A2(HMGA2)in prostate carcinoma tissues,and their correlation with the clinicopathological features.Methods Immunohistochemistry was used to assess the expression of Stathmin and HMGA2 in 23 cases of benign prostatic hyperplasia tissues and 75 cases of prostate carcinoma tissues of patients pathologically confirmed From january 2013 to august 2019 on Linyi People’s Hospital and Qingdao Municipal Hospital.χ2 test was used to compare groups.Results The positive rate of Stathmin expression was 80.00%(60/75)in prostate carcinoma tissues,significantly higher than 21.74%(5/23)in benign prostatic hyperplasia tissues(t=26.751,P<0.05).The expression of Stathmin was associated with histological grade and clinical stage(respectively,t=7.204,5.357,P<0.05).The positive rate of HMGA2 expression was 72.00%(54/75)in prostate carcinoma tissues,significantly higher than 13.04%(3/23)in benign prostatic hyperplasia tissues(t=25.143,P<0.05).The expression of HMGA2 was associated with histological grade,seminal vesicle invasion and clinical stage of prostate carcinoma(respectively,t=9.560,4.734,4.688,P<0.05).Conclusion The overexpression of Stathmin and HMGA2 are closely correlated with the onset and progression of prostate carcinoma.
作者 刘敬松 展英华 刘之俊 王世峰 Liu Jingsong;Zhan Yinghua;Liu Zhijun;Wang Shifeng(Department of Urology,Andrology,Linyi People’s Hospital,Linyi 276000,China;Department of Ultrasound,Linyi People’s Hospital,Linyi 276000,China;Department of Urology,Qingdao Municipal Hospital,Qingdao 266071,China;Department of Pathology,Linyi People’s Hospital,Linyi 276000,China)
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2020年第3期561-563,共3页 Chinese Journal of Experimental Surgery
关键词 前列腺癌 微管不稳定蛋白 高迁移率蛋A2 免疫组织化学方法 Prostate carcinoma Stathmin High mobility group A2 Immunohistochemical method
  • 相关文献

参考文献5

二级参考文献37

  • 1Cleynen I, Van de Ven WJ. The HMGA proteins:a myriad of functions(Review). Int J Oncol,2008,32 :289-305.
  • 2Wang X,Liu X,Li AY,et al. Overexpression of HMGA2 promotes me-tastasis and impacts survival of colorectal cancers. Clin Cancer Res,2011,17:2570-2580.
  • 3Hristov AC ,Cope L,Reyes MD,et al. HMGA2 protein expression cor-relates with lymph node metastasis and increased tumor grade in pan-creatic ductal adenocarcinoma. Mod Pathol ,2009,22 :43-49.
  • 4Bartuma H,Panagopoulos I,Collin A,et al. Expression levels of HMGA2in adipocytic tumors correlate with morphologic and cytogenetic sub-groups. Mol Cancer ,2009,8 :36-47.
  • 5Di Cello F,Hillion J,Hristov A,et al. HMGA2 participates in transfor-mation in human lung cancer. Mol Cancer Res,2008 ,6 :743-750.
  • 6Malek A,Bakhidze E,Noske A,et al. HMGA2 gene is a promising tar-get for ovarian cancer silencing therapy. Int J Cancer,2008,123 :348-356.
  • 7Wei JJ, Wu J, Luan C, et al. HMGA2 : a potential biomarker comple-ment to p53 for detection of early-stage high-grade papillary serouscarcinoma in fallopian tubes. Am J Surg Pathol ,2010,34 : 18-26.
  • 8Yang GL,Zhang LH,Bo JJ,et al. Overexpression of HMGA2 in blad-der cancer and its association with clinicopathologic; features and prog-nosis HMGA2 as a prognostic marker of bladder cancer. Eur J SurgOncol,2011,37 :265-271.
  • 9Fedele M,Palmieri D, Fusco A. HMGA2 : a pituitary tumour subtype-specific oncogene.. Mol Cell Endocrinol ,2010,326 ; 19-24.
  • 10Fedele M,Fusco A. HMGA and cancer. Biochim Biophys Acta,2010,1799:48-54.

共引文献23

同被引文献42

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部